Disclaimer: BPC-157 and TB-500 are strictly intended for laboratory research purposes only
TB-500 (a synthetic peptide fragment of thymosin beta-4) enhances cellular migration and blood vessel formation primarily through actin regulation and upregulation of angiogenic factors
While short-term preclinical studies suggest favorable safety, chronic administration effects on angiogenesis, growth factor signaling, and tissue remodeling over years of use remain unknown
The compound specifically targeted visceral adipose tissue, the metabolically harmful deep abdominal fat associated with insulin resistance and cardiovascular disease
BPC-157 is unique in its ability to support healing across multiple tissue types, including muscles, tendons, ligaments, joints, nerves, and the gut lining
Subcutaneous bioavailability may land somewhere around 30 to 80 percent depending on the site, and local injection could in theory help in superficial, low-blood-flow tissues like tendons